The Localization of Matrix Metalloproteinases-8 and -13 in Cholesteatoma, Deep-meatal and Post-auricular Skin: a Comparative Analysis
Overview
Authors
Affiliations
Conclusion: The presence of matrix metalloproteinase (MMP)-8 and MMP-13 was found to be significantly higher in cholesteatoma compared with post-auricular skin. The results show that the control group used has implications for further studies.
Objectives: To compare the presence of MMP-8 and MMP-13 in cholesteatoma, deep meatal and post-auricular skin. Our null hypothesis was that there was no difference in expressions of MMP-8 and MMP-13 in the three groups.
Materials And Methods: The study was carried out in a secondary care specialist centre and used prospective retrieval of specimens for immunohistological localization of MMP-8 and MMP-13. Eleven patients undergoing cholesteatoma surgery were recruited for the study. Eleven cholesteatoma specimens, 10 deep meatal skin specimens and 10 post-auricular skin specimens were analysed. Specimens were analysed by immunohistochemistry using monoclonal antibodies to MMP-8 and MMP-13. Two observers scored the slides independently in a blind fashion.
Results: The presence of MMP-8 and MMP-13 was found to be significantly higher in cholesteatoma compared to post-auricular skin (p=0.02, p=0.03, respectively). There were no significant differences in expression of MMP-8 and MMP-13 between cholesteatoma and deep meatal skin (p=0.08, p=0.09, respectively). There were no significant differences in the control groups.
Expression and Regulatory Mechanisms of MicroRNA in Cholesteatoma: A Systematic Review.
Dzaman K, Czerwaty K, Reichert T, Szczepanski M, Ludwig N Int J Mol Sci. 2023; 24(15).
PMID: 37569652 PMC: 10418341. DOI: 10.3390/ijms241512277.
The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
Xie S, Wang X, Ren J, Liu W Eur Arch Otorhinolaryngol. 2016; 274(5):2071-2078.
PMID: 27981350 DOI: 10.1007/s00405-016-4422-6.
Kao W, Gagnon P, Vogel J, Chole R Otol Neurotol. 2016; 37(7):977-83.
PMID: 27253076 PMC: 4942330. DOI: 10.1097/MAO.0000000000001088.
Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.
Rezende C, Souto R, Rapoport P, Campos L, Generato M Braz J Otorhinolaryngol. 2012; 78(3):116-21.
PMID: 22714856 PMC: 9446211.
Cholesteatoma growth and proliferation: posttranscriptional regulation by microRNA-21.
Friedland D, Eernisse R, Erbe C, Gupta N, Cioffi J Otol Neurotol. 2009; 30(7):998-1005.
PMID: 19672202 PMC: 2828528. DOI: 10.1097/MAO.0b013e3181b4e91f.